Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related conditions
characterized by systemic inflammation, a predominant IL-6 signature, an excellent …

Giant cell arteritis (GCA) is the most common vasculitis affecting people older than 50 years.
The last decades have shed new light on the clinical paradigm of this condition, expanding …

Objectives Clinical presentations of giant cell arteritis (GCA) are protean, and it is vital to
make a secure diagnosis and exclude mimics for urgent referrals with suspected GCA. The …

Objectives To characterize the effect of ultra-short glucocorticoids followed by Tocilizumab
monotherapy on the intima-media thickness (IMT) in GCA. Methods Eighteen GCA patients …

Early recognition of giant cell arteritis (GCA) is crucial to avoid the development of ischemic
vascular complications, such as blindness. The classic approach to making the diagnosis of …

Objectives This systematic review and meta-analysis aimed to evaluate the diagnostic value
of the halo sign in the assessment of GCA. Methods A systematic literature review was …

For years, clinicians and researchers working on giant cell arteritis have been battling with
the conundrum of a disease that displays a short-term steroid responsiveness but is …

Background Giant cell arteritis is a critically ischaemic disease with protean manifestations
that require urgent diagnosis and treatment. European Alliance of Associations for …

Objectives To evaluate the effectiveness of leflunomide as a steroid‐sparing agent among
Indian patients with giant cell arteritis (GCA) and to assess the changes of “halo sign” within …

Objectives To evaluate relapses in giant cell arteritis (GCA), investigate the utility of vascular
ultrasound to detect relapses, and develop and assess a composite score for GCA disease …